Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 257 followers
Latest posts
Last updated 40 minutes ago
Human medicines European public assessment report (EPAR): Avtozma, tocilizumab, Date of authorisation: 14/02/2025, Status: Authorised
43 minutes ago
Human medicines European public assessment report (EPAR): Avtozma, tocilizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Rivastigmine Sandoz, rivastigmine, Date of authorisation: 10/12/2009, Revision: 18, Status: Authorised
about 1 hour ago
Human medicines European public assessment report (EPAR): Rivastigmine Sandoz, rivastigmine, Date of...
Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Date of authorisation: 11/12/2009, Revision: 19, Status: Authorised
about 1 hour ago
Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Date of...
Human medicines European public assessment report (EPAR): Rivastigmine 1 A Pharma, rivastigmine, Date of authorisation: 11/12/2009, Revision: 19, Status: Authorised
about 1 hour ago
Human medicines European public assessment report (EPAR): Rivastigmine 1 A Pharma, rivastigmine...
Human medicines European public assessment report (EPAR): Rxulti, brexpiprazole, Date of authorisation: 26/07/2018, Revision: 7, Status: Authorised
about 3 hours ago
Human medicines European public assessment report (EPAR): Rxulti, brexpiprazole, Date of authorisation...
Human medicines European public assessment report (EPAR): Reblozyl, luspatercept, Date of authorisation: 25/06/2020, Revision: 9, Status: Authorised
about 4 hours ago
Human medicines European public assessment report (EPAR): Reblozyl, luspatercept, Date of authorisation...
Human medicines European public assessment report (EPAR): Vildagliptin / Metformin hydrochloride Accord, vildagliptin / metformin hydrochloride, Date of authorisation: 24/03/2022, Revision: 3, Status: Authorised
about 4 hours ago
Human medicines European public assessment report (EPAR): Vildagliptin / Metformin hydrochloride Accord...
Human medicines European public assessment report (EPAR): Ronapreve, casirivimab,imdevimab, Date of authorisation: 12/11/2021, Revision: 8, Status: Authorised
about 23 hours ago
Human medicines European public assessment report (EPAR): Ronapreve, casirivimab,imdevimab, Date of authorisation...
Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation: 16/01/2009, Revision: 47, Status: Authorised
about 23 hours ago
Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): MabThera, rituximab, Date of authorisation: 02/06/1998, Revision: 63, Status: Authorised
about 23 hours ago
Human medicines European public assessment report (EPAR): MabThera, rituximab, Date of authorisation...
Human medicines European public assessment report (EPAR): Jinarc, tolvaptan, Date of authorisation: 27/05/2015, Revision: 23, Status: Authorised
about 23 hours ago
Human medicines European public assessment report (EPAR): Jinarc, tolvaptan, Date of authorisation...
Human medicines European public assessment report (EPAR): Seffalair Spiromax, salmeterol,fluticasone propionate, Date of authorisation: 26/03/2021, Revision: 2, Status: Authorised
about 23 hours ago
Human medicines European public assessment report (EPAR): Seffalair Spiromax, salmeterol,fluticasone propionate, Date...